From Fibrositis to Functional Somatic Syndromes to a Bell-Shaped Curve of Pain and Sensory Sensitivity: Evolution of a Clinical Construct

Rheumatic Disease Clinics of North America

Volumn 35, Issue 2, 2009, Pages 233-251

  Ablin, Kobby ^a   Clauw, Daniel J ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Fatigue; Fibromyalgia; Functional; Pain; Somatic

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CANNABINOID; CATECHOL METHYLTRANSFERASE; CHOLECYSTOKININ; CYTOKINE; DOPAMINE; DULOXETINE; ENKEPHALIN; EXCITATORY AMINO ACID; GABAPENTIN; GLUTAMIC ACID; NERVE GROWTH FACTOR; NORADRENALIN; OPIATE AGONIST; PREGABALIN; SEROTONIN; SUBSTANCE P; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; ANXIETY; AUTOIMMUNITY; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FIBROMYALGIA; FIBROSITIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEADACHE; HUMAN; HYPERALGESIA; IRRITABLE COLON; KINESIOTHERAPY; LOW BACK PAIN; MENTAL DISEASE; MUSCLE SPASM; NOCICEPTION; NONHUMAN; PAIN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; TEMPOROMANDIBULAR JOINT DISORDER;

FATIGUE; FIBROMYALGIA; HUMANS; PAIN; PSYCHOPHYSIOLOGY;

EID: 67651207822     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.06.006     Document Type: Review

References (136)

1. Clauw D.J., and Katz P. The overlap between fibromyalgia and inflammatory rheumatic diseases: when and why does it occur?. J Clin Rheumatol 1 (1995) 335-341
2. McBeth J., and Jones K. Epidemiology of chronic musculoskeletal pain. Clin Rheumatol 21 3 (2007) 403-425
3. Clauw D.J., Engel Jr. C.C., Aronowitz R., et al. Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med 45 10 (2003) 1040-1048
4. Simms R.W. Fibromyalgia is not a muscle disorder. Am J Med Sci 315 6 (1998) 346-350
5. Moldofsky H., and Lue F.A. The relationship of alpha and delta EEG frequencies to pain and mood in 'fibrositis' patients treated with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol 50 1-2 (1980) 71-80
6. Moldofsky H., Scarisbrick P., England R., et al. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37 4 (1975) 341-351
7. Hudson J.I., Hudson M.S., Pliner L.F., et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 142 4 (1985) 441-446
8. Hudson J.I., and Pope H.G.J. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"?. J Rheumatol Suppl 19 (1989) 15-22
9. Yunus M.B. Primary fibromyalgia syndrome: current concepts. Compr Ther 10 8 (1984) 21-28
10. Bengtsson A., and Henriksson K.G. The muscle in fibromyalgia: a review of Swedish studies. J Rheumatol Suppl 19 (1989) 144-149
11. Bennett R.M., Clark S.R., Goldberg L., et al. Aerobic fitness in patients with fibrositis: a controlled study of respiratory gas exchange and 133×enon clearance from exercising muscle. Arthritis Rheum 32 4 (1989) 454-460
12. Bennett R.M. Muscle physiology and cold reactivity in the fibromyalgia syndrome. Rheum Dis Clin North Am 15 1 (1989) 135-147
13. Yunus M.B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37 6 (2008) 339-352
14. Aaron L.A., and Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134 9 Pt 2 (2001) 868-881
15. Aaron L.A., Herrell R., Ashton S., et al. Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med 16 1 (2001) 24-31
16. Wysenbeek A.J., Shapira Y., and Leibovici L. Primary fibromyalgia and the chronic fatigue syndrome. Rheumatol Int 10 6 (1991) 227-229
17. Hudson J.I., Goldenberg D.L., Pope Jr. H.G., et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92 4 (1992) 363-367
18. Buchwald D., and Garron D.C. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. [see comments]. Arch Intern Med 154 18 (1994) 2049-2053
19. Jason L.A., Taylor R.R., and Kennedy C.L. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. [in process citation]. Psychosom Med 62 5 (2000) 655-663
20. White K.P., Speechley M., Harth M., et al. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population: a controlled study. Scand J Rheumatol 29 1 (2000) 44-51
21. Aaron L.A., Burke M.M., and Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160 2 (2000) 221-227
22. Yunus M., Masi A.T., Calabro J.J., et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11 1 (1981) 151-171
23. Bengtsson A., Henriksson K.G., Jorfeldt L., et al. Primary fibromyalgia: a clinical and laboratory study of 55 patients. Scand J Rheumatol 15 3 (1986) 340-347
24. Goldenberg D.L. Fibromyalgia syndrome: an emerging but controversial condition. J Am Med Assoc 257 20 (1987) 2782-2787
25. Romano T.J. Coexistence of irritable bowel syndrome and fibromyalgia. W V Med J 84 2 (1988) 16-18
26. Yunus M.B., Masi A.T., and Aldag J.C. A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol Suppl 19 (1989) 62-71
27. Triadafilopoulos G., Simms R.W., and Goldenberg D.L. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 36 1 (1991) 59-64
28. Sperber A.D., Atzmon Y., Neumann L., et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 94 12 (1999) 3541-3546
29. Sivri A., Cindas A., Dincer F., et al. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. [see comments]. Clin Rheumatol 15 3 (1996) 283-286
30. Wolfe F., Ross K., Anderson J., et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 1 (1995) 19-28
31. Aaron L.A., Bradley L.A., Alarcon G.S., et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. [see comments]. Arthritis Rheum 39 3 (1996) 436-445
32. Drossman D.A., Li Z.M., Andruzzi E., et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 38 9 (1993) 1569-1580
33. Clauw D.J. Fibromyalgia: update on mechanisms and management. J Clin Rheumatol 13 2 (2007) 102-109
34. Woolf C.J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140 6 (2004) 441-451
35. Fukuda K., Nisenbaum R., Stewart G., et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. J Am Med Assoc 280 11 (1998) 981-988
36. Kato K., Sullivan P.F., Evengard B., et al. A population-based twin study of functional somatic syndromes. Psychol Med 39 (2008) 1-9
37. Buskila D., Sarzi-Puttini P., and Ablin J.N. The genetics of fibromyalgia syndrome. Pharmacogenomics 8 1 (2007) 67-74
38. Arnold L.M., Hudson J.I., Hess E.V., et al. Family study of fibromyalgia. Arthritis Rheum 50 3 (2004) 944-952
39. Williams D.A., Brown S.C., Clauw D.J., et al. Self-reported symptoms before and after September 11 in patients with fibromyalgia. JAMA 289 13 (2003) 1637-1638
40. Clauw D.J., Mease P., Palmer R.H., et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30 11 (2008) 1988-2004
41. Raphael K.G., Natelson B.H., Janal M.N., et al. A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain 100 1-2 (2002) 131-139
42. Clauw D.J., and Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4 3 (1997) 134-153
43. Maixner W., Fillingim R., Booker D., et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 63 3 (1995) 341-351
44. Moshiree B., Price D.D., Robinson M.E., et al. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 23 4 (2007) 323-330
45. Kato K., Sullivan P.F., Evengard B., et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166 15 (2006) 1649-1654
46. Giesecke T., Gracely R.H., Williams D.A., et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52 5 (2005) 1577-1584
47. Diatchenko L., Nackley A.G., Slade G.D., et al. Idiopathic pain disorders: pathways of vulnerability. Pain 123 3 (2006) 226-230
48. Armitage R., Landis C., Hoffmann R., et al. Power spectral analysis of sleep EEG in twins discordant for chronic fatigue syndrome. J Psychosom Res 66 1 (2009) 51-57
49. Sherlin L., Budzynski T., Kogan B.H., et al. Low-resolution electromagnetic brain tomography (LORETA) of monozygotic twins discordant for chronic fatigue syndrome. Neuroimage 34 4 (2007) 1438-1442
50. Buskila D., Neumann L., Vaisberg G., et al. Increased rates of fibromyalgia following cervical spine injury: a controlled study of 161 cases of traumatic injury. [see comments]. Arthritis Rheum 40 3 (1997) 446-452
51. McLean S.A., and Clauw D.J. Predicting chronic symptoms after an acute "stressor": lessons learned from 3 medical conditions. Med Hypotheses 63 4 (2004) 653-658
52. Unwin C., Blatchley N., Coker W., et al. Health of UK servicemen who served in Persian Gulf War. Lancet 353 9148 (1999) 169-178
53. Hyams K.C., Wignall F.S., and Roswell R. War syndromes and their evaluation: from the US Civil War to the Persian Gulf War. Ann Intern Med 125 5 (1996) 398-405
54. Clauw D.J. The health consequences of the first Gulf War. Br Med J 327 (2003) 1357-1358
55. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56 4 (1997) 268-271
56. Wolfe F., and Rasker J.J. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol 33 11 (2006) 2291-2299
57. Clauw D.J., and Witter J. Pain and rheumatology: thinking outside the joint. Arthritis Rheum 60 2 (2009) 321-324
58. Harris R.E., Sundgren P.C., Pang Y., et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58 3 (2008) 903-907
59. Craig A.D. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 13 4 (2003) 500-505
60. Brooks J.C., and Tracey I. The insula: a multidimensional integration site for pain. Pain 128 1-2 (2007) 1-2
61. Buskila D., Neumann L., Hazanov I., et al. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26 3 (1996) 605-611
62. Kato K., Sullivan P.F., Evengard B., et al. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54 5 (2006) 1682-1686
63. Camilleri M., Atanasova E., Carlson P.J., et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123 2 (2002) 425-432
64. Whitehead W.E. Twin studies used to prove that the comorbidity of major depressive disorder with irritable bowel syndrome is NOT influenced by heredity. Am J Gastroenterol 102 10 (2007) 2230-2231
65. Tietjen G.E., Herial N.A., Hardgrove J., et al. Migraine comorbidity constellations. Headache 47 6 (2007) 857-865
66. Apkarian A.V., Bushnell M.C., Treede R.D., et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9 4 (2005) 463-484
67. Bengtsson B., and Thorson J. Back pain: a study of twins. Acta Genet Med Gemellol (Roma) 40 1 (1991) 83-90
68. Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol 21 3 (2007) 535-547
69. Mogil J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A 96 14 (1999) 7744-7751
70. Staud R., and Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr 13 3 Suppl 5 (2008) 12-17
71. Granges G., and Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36 5 (1993) 642-646
72. Wolfe F., Ross K., Anderson J., et al. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22 1 (1995) 151-156
73. Gracely R.H., Grant M.A., and Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17 4 (2003) 593-609
74. Jensen K., Andersen H.O., Olesen J., et al. Pressure-pain threshold in human temporal region: evaluation of a new pressure algometer. Pain 25 3 (1986) 313-323
75. Petzke F., Gracely R.H., Park K.M., et al. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 30 3 (2003) 567-574
76. Petzke F., Gracely R.H., Khine A., et al. Pain sensitivity in patients with fibromyalgia (fibromyalgia): expectancy effects on pain measurements. Arthritis Rheum 42 Suppl 9 (1999) S342
77. Petzke F., Khine A., Williams D., et al. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness. J Rheumatol 28 11 (2001) 2568-2569
78. Petzke F., Clauw D.J., Ambrose K., et al. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 105 3 (2003) 403-413
79. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58 2 (1994) 185-193
80. Kosek E., and Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70 1 (1997) 41-51
81. Geisser M.E., Casey K.L., Brucksch C.B., et al. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102 3 (2003) 243-250
82. Kosek E., Ekholm J., and Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68 2-3 (1996) 375-383
83. Arroyo J.F., and Cohen M.L. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 20 11 (1993) 1925-1931
84. Gerster J.C., and Hadj-Djilani A. Hearing and vestibular abnormalities in primary fibrositis syndrome. J Rheumatol 11 5 (1984) 678-680
85. McDermid A.J., Rollman G.B., and McCain G.A. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66 2-3 (1996) 133-144
86. Geisser M.E., Gracely R.H., Giesecke T., et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 11 2 (2007) 202-207
87. Tracey I., and Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 55 3 (2007) 377-391
88. Craig A.D. Human feelings: why are some more aware than others?. Trends Cogn Sci 8 6 (2004) 239-241
89. Schmulson M., Chang L., Naliboff B., et al. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol 95 1 (2000) 152-156
90. Drewes A.M., Petersen P., Rossel P., et al. Sensitivity and distensibility of the rectum and sigmoid colon in patients with irritable bowel syndrome. Scand J Gastroenterol 36 8 (2001) 827-832
91. Bouin M., Plourde V., Boivin M., et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 122 7 (2002) 1771-1777
92. Bouin M., Lupien F., Riberdy M., et al. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation?. Neurogastroenterol Motil 16 3 (2004) 311-314
93. Rossel P., Pedersen P., Niddam D., et al. Cerebral response to electric stimulation of the colon and abdominal skin in healthy subjects and patients with irritable bowel syndrome. Scand J Gastroenterol 36 12 (2001) 1259-1266
94. Rossel P., Drewes A.M., Petersen P., et al. Pain produced by electric stimulation of the rectum in patients with irritable bowel syndrome: further evidence of visceral hyperalgesia. Scand J Gastroenterol 34 10 (1999) 1001-1006
95. Costantini M., Sturniolo G.C., Zaninotto G., et al. Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci 38 2 (1993) 206-212
96. Rodrigues A.C., Nicholas V.G., Schmidt S., et al. Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome. Pain 115 1-2 (2005) 5-11
97. Bouin M., Meunier P., Riberdy-Poitras M., et al. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?. Dig Dis Sci 46 11 (2001) 2542-2548
98. Gracely R.H., Petzke F., Wolf J.M., et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 5 (2002) 1333-1343
99. Drossman D.A. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut 54 5 (2005) 569-573
100. Rapps N., van Oudenhove L., Enck P., et al. Brain imaging of visceral functions in healthy volunteers and irritable bowel syndrome patients. J Psychosom Res 64 6 (2008) 599-604
101. Giesecke T., Gracely R.H., Grant M.A., et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50 2 (2004) 613-623
102. Langemark M., Jensen K., Jensen T.S., et al. Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain 38 2 (1989) 203-210
103. Gobel H., Weigle L., Kropp P., et al. Pain sensitivity and pain reactivity of pericranial muscles in migraine and tension-type headache. Cephalalgia 12 3 (1992) 142-151
104. Flor H., Diers M., and Birbaumer N. Peripheral and electrocortical responses to painful and non-painful stimulation in chronic pain patients, tension headache patients and healthy controls. Neurosci Lett 361 1-3 (2004) 147-150
105. Jensen R., Rasmussen B.K., Pedersen B., et al. Muscle tenderness and pressure pain thresholds in headache: a population study. Pain 52 2 (1993) 193-199
106. Clauw D.J., Schmidt M., Radulovic D., et al. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res 31 1 (1997) 125-131
107. Ness T.J., Powell-Boone T., Cannon R., et al. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J Urol 173 6 (2005) 1983-1987
108. Giesecke J., Reed B.D., Haefner H.K., et al. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 104 1 (2004) 126-133
109. Danziger N., Gautron M., Le Bars D., et al. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. Pain 91 3 (2001) 287-296
110. Edwards R.R., Ness T.J., Weigent D.A., et al. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain 106 3 (2003) 427-437
111. Le Bars D., Villanueva L., Bouhassira D., et al. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter 4 (1992) 55-65
112. King C.D., Wong F., Currie T., et al. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain 143 3 (2009) 172-178
113. de Souza J.B., Potvin S., Goffaux P., et al. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain 25 2 (2009) 123-127
114. Zubieta J.K., Smith Y.R., Bueller J.A., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 5528 (2001) 311-315
115. Diatchenko L., Nackley A.G., Slade G.D., et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 125 3 (2006) 216-224
116. Diatchenko L., Slade G.D., Nackley A.G., et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14 1 (2005) 135-143
117. Nackley A.G., Tan K.S., Fecho K., et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 128 3 (2007) 199-208
118. Millan M.J. Descending control of pain. Prog Neurobiol 66 6 (2002) 355-474
119. Yaksh T.L. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 22 5 (1985) 845-858
120. Bajic D., Proudfit H.K., and Van Bockstaele E.J. Periaqueductal gray neurons monosynaptically innervate extranuclear noradrenergic dendrites in the rat pericoerulear region. J Comp Neurol 427 4 (2000) 649-662
121. Chang P.F., Arendt-Nielsen L., Graven-Nielsen T., et al. Psychophysical and EEG responses to repeated experimental muscle pain in humans: pain intensity encodes EEG activity. Brain Res Bull 59 6 (2003) 533-543
122. Giovengo S.L., Russell I.J., and Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26 7 (1999) 1564-1569
123. Sarchielli P., Mancini M.L., Floridi A., et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8 9 (2007) 737-745
124. Russell I.J., Orr M.D., Littman B., et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37 11 (1994) 1593-1601
125. Russell I.J. Neurochemical pathogenesis of fibromyalgia. Z Rheumatol 57 Suppl 2 (1998) 63-66
126. Harris R.E., Clauw D.J., Scott D.J., et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27 37 (2007) 10000-10006
127. Baraniuk J.N., Whalen G., Cunningham J., et al. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5 (2004) 48
128. Russell I.J. Neurotransmitters, cytokines, hormones and the immune system in chronic neuropathic pain. In: Wallace D.J. (Ed). Fibromyalgia and other central syndromes (2005), Lippincott Williams & Wilkins, Philadelphia 63-79
129. Bryson H.M., and Wilde M.I. Amitriptyline: a review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 8 6 (1996) 459-476
130. van Ophoven A., and Hertle L. Long-term results of amitriptyline treatment for interstitial cystitis. J Urol 174 5 (2005) 1837-1840
131. Lynch M.E. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 26 1 (2001) 30-36
132. Arnold L.M. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 8 Suppl 2 (2007) S63-S74
133. Arnold L.M., Goldenberg D.L., Stanford S.B., et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56 4 (2007) 1336-1344
134. Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol 21 1 (2007) 153-166
135. Deuster P.A. Exercise in the prevention and treatment of chronic disorders. Womens Health Issues 6 6 (1996) 320-331
136. Williams D.A. Cognitive and behavioral approaches to chronic pain. In: Wallace D.J., and Clauw D.J. (Eds). Fibromyalgia and other central pain syndromes (2005), Lippincott Williams & Wilkins, Philadelphia 343-352